Comparation of time-course, dose-effect, influencing factors and adverse events of biologics in the treatment of adults with moderate to severe plaque psoriasis

INTRODUCTION: Biologics is used for treating moderate to severe plaque psoriasis (MSPP), which represent one of the foremost therapeutic advancements in disease of dermatology. Up to now, the relative efficacy and safety across approved andinvestigational biologics for MSPP is still unclear. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Weiqi, Yu, Boran, Yan, Ya, Zhao, Libo, Zhao, Rongsheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10248012/
https://www.ncbi.nlm.nih.gov/pubmed/37304299
http://dx.doi.org/10.3389/fimmu.2023.1151977

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10248012/
https://www.ncbi.nlm.nih.gov/pubmed/37304299
http://dx.doi.org/10.3389/fimmu.2023.1151977

Ejemplares similares